MDGL compared with UTHR: revenue, margins and what each company keeps, and the suppliers and customers both name

MDGLMadrigal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

UTHRUnited Therapeutics Corp

Mkt capRevenueRevenue

Compare

MDGLMadrigal Pharmaceuticals, Inc.

UTHRUnited Therapeutics Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MDGL

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±12.7%▼−8.08%×0.64

Q2 FY26±10.5%▼−9.83%×0.93

Q1 FY26±9.2%▲+7.42%×0.80

Feb 19 '26±6.2%▼−11.11%×1.79

UTHR

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±6.2%▲+1.19%×0.19

Q2 FY26±6.1%▲+0.06%×0.02

= impliedMDGL realized, solidUTHR realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

May 6 '26

—

▲+4.29%

—

Q1 FY26—▲+13.03%—

MDGLMadrigal Pharmaceuticals, Inc.

396.55▼−0.89%· post 403.00

Mkt cap$9.3BRevenue$431MQ3 FY26Revenue$958MFY25

UTHRUnited Therapeutics Corp

565.64▼−0.01%· post 557.33

ClosedNov 6 '26

Mkt cap$23.9BRevenue$833MQ3 FY26Revenue$3.2BFY25

Compare

ClosedNov 6 '26

MDGLMadrigal Pharmaceuticals, Inc.

UTHRUnited Therapeutics Corp

396.55▼−0.89%post 403.00

Price

565.64▼−0.01%post 557.33

$9.3B

Mkt cap

$23.9B

Q3 FY26$431M

Revenue

$833MQ3 FY26

FY25$958M

Revenue

$3.2BFY25

MDGL396.55▼−0.89%vsUTHR565.64▼−0.01%ClosedNov 6 '26